Potentiation of the bronchoprotective effects of vasoactive intestinal peptide, isoprenaline, and theophylline against histamine challenge in anaesthetised guinea pigs by adrenomedullin

Thorax

Volumn 51, Issue 12, 1996, Pages 1199-1202

  Kanazawa, H ^a   Kawaguchi, T ^a   Fujii, T ^a   Shoji, S ^a   Hirata, K ^a   Kudoh, S ^a   Kurihara, N ^a   Yoshikawa, J ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

adrenomedullin; bronchoprotection; cyclic AMP

Indexed keywords

ADRENOMEDULLIN; CYCLIC AMP; HISTAMINE; ISOPRENALINE; THEOPHYLLINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GUINEA PIG; LUNG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0029800305     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.12.1199     Document Type: Article

References (20)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60.
2. Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H, Eto T. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precussor. FEBS Lett 1994;338:306-10.
3. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 1995;136:4099-105.
4. Kanazawa H, Kurihara N, Hirata K, Kudoh S, Kawaguchi T, Takeda T. Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator. Biochem Biophys Res Commun 1994;205:251-4.
5. Polak JM, Bloom SR. Regulatory peptides of the gastrointestinal and respiratory tracts. Arch Int Pharmacodyn 1986;280:16-49.
6. Dey RD, Shannon WA, Said SI. Localization of VIP immunoreceptor nerves in airways and pulmonary vessels of dogs, cats and human subjects. Cell Tissue 1981;220: 231-8.
7. Palmer JB, Cuss FMC, Barnes PJ. VIP and PHM and their role in non-adrenergic inhibitory responses in isolated human airways. J Appl Physiol 1986;61:1322-8.
8. Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DWP. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 1993; 265:1213-33.
9. Dusser DJ, Umeno E, Graf PD, Djokic TD, Borson DB, Nadel JA. Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo. J Appl Physiol 1988;65:2585-91.
10. Diamond L, Szarek JL, Gillespie MN, Altiere RJ. In vivo hronchodilatory activity of vasoactive intestinal peptide in the cats. Am Rev Respir Dis 1983;128:827-32.
11. Said SI, Geumi A, Hara N, Bronchodilator effet of VIP in vivo: protection against bronchoconstriction induced by histamine and prostaglandin F2, New York: Raven Press, 1982: 185-91.
12. Barnes PJ, Dixon CMS. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in man. Am Rev Respir Dis 1984;130:162-6.
13. Palmer JBD, Cuss FMC, Warren JB, Barnes PJ. The effect of infused vasoactive intestinal peptide on airway function in normal subjects. Thorax 1986;41:663-6.
14. Bungaad A, Enehjelm SD, Aggestrop S. Pretreatment of exercise-induced asthma with inhaled vasoactive intestinal peptide. Eur J Respir Dis 1983;64:427-9.
15. O'Donnell M, Garippa RJ, Rinaldi N, Selig WM, Smiko B, Renzetti L, et al. Ro25-1553: a novel long-acting vasoactive intestinal peptide agonist. Part 1 : In vitro and in vivo bronchodilator studies. J Pharmacol Exp Ther 1994;270: 1282-8.
16. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994;340: 220-30.
17. Torphy TJ, Burman M, Huang LBF, Tucker SS. Inhibition of the low Km cyclic AMP phosphodiesterase in intact trachealis by SKF 94836: mechanical and biochemical responses. J Pharmacol Exp Ther 1988;246:845-50.
18. De Boer J, Philpott AJ, Van Amsterdam RGM, Shahid M, Zaagsma J, Nicholson CD. Human bronchial cyclic nucleotide phosphodiesterase isozymes: biochemical and pharmacological analysis using selective inhibitors,Br J Pharmacol 1992;106:1028-32.
19. Santing RE, Olymulder CG, Van der Molen K, Meurs H, Zaagsma J. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol 1995;275:75-82.
20. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993;241:271-3.